To: Barron Von Hymen who wrote (7361 ) 4/9/1999 9:04:00 PM From: BigKNY3 Read Replies (1) | Respond to of 9523
The Big Pharma Report: 4/09/99 Have PFun! BigKNY3 PS Time to Celebrate a New PFE Highmarimba.com ________________________________________________________ Big Pharma Scoreboard 4/09/99 -Big Pharma attains an all-time high of 77.64 (+9.5% YTD) -ABT (+7.1% week) sparked Pharma rally with an excellent 1 Qt EPS report -PFE (+4.6%) reached all-time high of 146 13/16 in anticipation of next week's expected strong 1 Qt EPS report. -SGP and WLA both had 8% bounces. . Price % Chg % Chg % Chg Rank . 04/09/99 Week April YTD 1999 1 Amgen 78.06 1.5% 19.9% 49.3% 2 Amer 68.38 2.8% 9.7% 21.3% 3 J&J 98.00 4.1% 9.5% 16.8% 4 Pfizer 146.00 4.6% 5.2% 16.8% 5 Merck 83.25 4.1% -1.7% 12.9% 6 Pharma 62.50 -0.1% 14.4% 10.4% 7 Scher 59.81 8.1% -0.8% 8.3% 8 Abbott 50.94 7.1% 1.1% 4.0% 9 Lilly 90.25 3.9% -10.2% 1.5% 10 Smith 70.13 -3.7% 0.5% 0.9% 11 Bristol 64.81 2.6% 1.8% -3.1% 12 Glaxo 66.00 -5.6% 4.5% -5.0% 13 Warner 71.25 8.0% -3.7% -5.2% Big Pharma 77.64 2.9% 3.4% 9.5% Dow 10,174 4.5% 5.1% 10.8% S&P 500 1,348 4.2% 3.9% 9.7% NASDAQ 2,593 4.0% 7.6% 18.2% News/chart/quote links to Big Pharma and ED stocks: Yahoo! PFE News biz.yahoo.com Five Day Chart of PFE versus the Dow quicken.com A great PFE Stat Website dailystocks.com Labpuppy.com Drug Stock Commentary (scroll down after opening) labpuppy.com A New Investment Website Worth A Trybridge.com Big Pharma Yahoo Link quote.yahoo.com Motley Fool Link quote.fool.com ED Stocks Yahoo Linkquote.yahoo.com Motley Fool Linkquote.fool.com PFE Split Information -On the April 22, 1999 Annual Meeting, PFE shareholders will officially approved an increase in authorized outstanding shares that will permit a 3-1 split. -Following the Annual Meeting, the PFE Board is scheduled to meet and announce the 3-1 split and its effective date....Expected to be following the June 30, 1999 close. The 1999 Pharma Portfolio Challenge: Motley Fool /SI Challenge Highlights -Ron Flanagan (+26.1%) remains #1 with an equal trifecta of PFE/MRK/AMGN (Portfolio: 33% PFE/MRK/AMGN, 1% Cash). -MBTAY (+24.9%) moved up to second place (Portfolio: 75% PFE, 25% AMGN) -McMenus(+24.0%) is in the place position (Portfolio: 40% PFE, 25% AMGN/MRK, 10%:JNJ) -The top 7 places have AMGN in their portfolios. -The five 100% PFErs (+16.8%) remain in 12th place (Portfolio: 100% PFE) -Supporting the principles behind the Peabody Model: PEABODY PURCHASE (+6.0%) is beating the PFE DRIP (+3.3%). Both portfolios are weighed down due to their large cash accounts in the growing Big Pharma market. -SHORT COX II (-14.8%) is in 64th place (Portfolio: 50% short PFE; 50% short MRK) -SHORT PFE (-16.8%) remains in the new cellar dweller (Portfolio: 100% short PFE) -Not a single Pharmer or PFEr Portfolio is in the red!! Click here for a breakdown of the holdings of the 64 Challenge portfolioswww3.techstocks.com